United States Immune Globulins Market Report 2018

March 2018 | 106 pages | ID: U84C3A448B9EN
QYResearch

Abstracts

In this report, the United States Immune Globulins market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Immune Globulins in these regions, from 2013 to 2025 (forecast).

United States Immune Globulins market competition by top manufacturers/players, with Immune Globulins sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter
• Grifols
• CSL
• Octapharma
• Biotest
• Kedrion
• Hualan Bio
• CNBG
• Shanghai RAAS
• CBPO
• LFB Group
• BPL
• Sichuan Yuanda Shuyang

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• IVIg Liquid
• IVIg Powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Immunodeficiency
• Autoimmune Disease
• Acute Infection

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Immune Globulins Market Report 2018

1 IMMUNE GLOBULINS OVERVIEW

1.1 Product Overview and Scope of Immune Globulins
1.2 Classification of Immune Globulins by Product Category
  1.2.1 United States Immune Globulins Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Immune Globulins Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 IVIg Liquid
  1.2.4 IVIg Powder
1.3 United States Immune Globulins Market by Application/End Users
  1.3.1 United States Immune Globulins Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Immunodeficiency
  1.3.3 Autoimmune Disease
  1.3.4 Acute Infection
1.4 United States Immune Globulins Market by Region
  1.4.1 United States Immune Globulins Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Immune Globulins Status and Prospect (2013-2025)
  1.4.3 Southwest Immune Globulins Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Immune Globulins Status and Prospect (2013-2025)
  1.4.5 New England Immune Globulins Status and Prospect (2013-2025)
  1.4.6 The South Immune Globulins Status and Prospect (2013-2025)
  1.4.7 The Midwest Immune Globulins Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Immune Globulins (2013-2025)
  1.5.1 United States Immune Globulins Sales and Growth Rate (2013-2025)
  1.5.2 United States Immune Globulins Revenue and Growth Rate (2013-2025)

2 UNITED STATES IMMUNE GLOBULINS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Immune Globulins Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Immune Globulins Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Immune Globulins Average Price by Players/Suppliers (2013-2018)
2.4 United States Immune Globulins Market Competitive Situation and Trends
  2.4.1 United States Immune Globulins Market Concentration Rate
  2.4.2 United States Immune Globulins Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immune Globulins Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMMUNE GLOBULINS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Immune Globulins Sales and Market Share by Region (2013-2018)
3.2 United States Immune Globulins Revenue and Market Share by Region (2013-2018)
3.3 United States Immune Globulins Price by Region (2013-2018)

4 UNITED STATES IMMUNE GLOBULINS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Immune Globulins Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Immune Globulins Revenue and Market Share by Type (2013-2018)
4.3 United States Immune Globulins Price by Type (2013-2018)
4.4 United States Immune Globulins Sales Growth Rate by Type (2013-2018)

5 UNITED STATES IMMUNE GLOBULINS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Immune Globulins Sales and Market Share by Application (2013-2018)
5.2 United States Immune Globulins Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNE GLOBULINS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immune Globulins Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Grifols
  6.2.2 Immune Globulins Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Grifols Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.2 Immune Globulins Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Octapharma
  6.4.2 Immune Globulins Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Octapharma Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biotest
  6.5.2 Immune Globulins Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biotest Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Kedrion
  6.6.2 Immune Globulins Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Hualan Bio
  6.7.2 Immune Globulins Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hualan Bio Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 CNBG
  6.8.2 Immune Globulins Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 CNBG Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Shanghai RAAS
  6.9.2 Immune Globulins Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shanghai RAAS Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 CBPO
  6.10.2 Immune Globulins Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 CBPO Immune Globulins Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 LFB Group
6.12 BPL
6.13 Sichuan Yuanda Shuyang

7 IMMUNE GLOBULINS MANUFACTURING COST ANALYSIS

7.1 Immune Globulins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immune Globulins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immune Globulins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immune Globulins Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNE GLOBULINS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Immune Globulins Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Immune Globulins Sales Volume Forecast by Type (2018-2025)
11.3 United States Immune Globulins Sales Volume Forecast by Application (2018-2025)
11.4 United States Immune Globulins Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Immune Globulins
Figure United States Immune Globulins Market Size (K Units) by Type (2013-2025)
Figure United States Immune Globulins Sales Volume Market Share by Type (Product Category) in 2017
Figure IVIg Liquid Product Picture
Figure IVIg Powder Product Picture
Figure United States Immune Globulins Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Immune Globulins by Application in 2017
Figure Immunodeficiency Examples
Table Key Downstream Customer in Immunodeficiency
Figure Autoimmune Disease Examples
Table Key Downstream Customer in Autoimmune Disease
Figure Acute Infection Examples
Table Key Downstream Customer in Acute Infection
Figure United States Immune Globulins Market Size (Million USD) by Region (2013-2025)
Figure The West Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immune Globulins Sales (K Units) and Growth Rate (2013-2025)
Figure United States Immune Globulins Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immune Globulins Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Immune Globulins Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Immune Globulins Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immune Globulins Sales Share by Players/Suppliers
Figure 2017 United States Immune Globulins Sales Share by Players/Suppliers
Figure United States Immune Globulins Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Immune Globulins Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Immune Globulins Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immune Globulins Revenue Share by Players/Suppliers
Figure 2017 United States Immune Globulins Revenue Share by Players/Suppliers
Table United States Market Immune Globulins Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Immune Globulins Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Immune Globulins Market Share of Top 3 Players/Suppliers
Figure United States Immune Globulins Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immune Globulins Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immune Globulins Product Category
Table United States Immune Globulins Sales (K Units) by Region (2013-2018)
Table United States Immune Globulins Sales Share by Region (2013-2018)
Figure United States Immune Globulins Sales Share by Region (2013-2018)
Figure United States Immune Globulins Sales Market Share by Region in 2017
Table United States Immune Globulins Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Immune Globulins Revenue Share by Region (2013-2018)
Figure United States Immune Globulins Revenue Market Share by Region (2013-2018)
Figure United States Immune Globulins Revenue Market Share by Region in 2017
Table United States Immune Globulins Price (USD/Unit) by Region (2013-2018)
Table United States Immune Globulins Sales (K Units) by Type (2013-2018)
Table United States Immune Globulins Sales Share by Type (2013-2018)
Figure United States Immune Globulins Sales Share by Type (2013-2018)
Figure United States Immune Globulins Sales Market Share by Type in 2017
Table United States Immune Globulins Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Immune Globulins Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immune Globulins by Type (2013-2018)
Figure Revenue Market Share of Immune Globulins by Type in 2017
Table United States Immune Globulins Price (USD/Unit) by Types (2013-2018)
Figure United States Immune Globulins Sales Growth Rate by Type (2013-2018)
Table United States Immune Globulins Sales (K Units) by Application (2013-2018)
Table United States Immune Globulins Sales Market Share by Application (2013-2018)
Figure United States Immune Globulins Sales Market Share by Application (2013-2018)
Figure United States Immune Globulins Sales Market Share by Application in 2017
Table United States Immune Globulins Sales Growth Rate by Application (2013-2018)
Figure United States Immune Globulins Sales Growth Rate by Application (2013-2018)
Table Baxter Basic Information List
Table Baxter Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Baxter Immune Globulins Sales Growth Rate (2013-2018)
Figure Baxter Immune Globulins Sales Market Share in United States (2013-2018)
Figure Baxter Immune Globulins Revenue Market Share in United States (2013-2018)
Table Grifols Basic Information List
Table Grifols Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Immune Globulins Sales Growth Rate (2013-2018)
Figure Grifols Immune Globulins Sales Market Share in United States (2013-2018)
Figure Grifols Immune Globulins Revenue Market Share in United States (2013-2018)
Table CSL Basic Information List
Table CSL Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Immune Globulins Sales Growth Rate (2013-2018)
Figure CSL Immune Globulins Sales Market Share in United States (2013-2018)
Figure CSL Immune Globulins Revenue Market Share in United States (2013-2018)
Table Octapharma Basic Information List
Table Octapharma Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Immune Globulins Sales Growth Rate (2013-2018)
Figure Octapharma Immune Globulins Sales Market Share in United States (2013-2018)
Figure Octapharma Immune Globulins Revenue Market Share in United States (2013-2018)
Table Biotest Basic Information List
Table Biotest Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biotest Immune Globulins Sales Growth Rate (2013-2018)
Figure Biotest Immune Globulins Sales Market Share in United States (2013-2018)
Figure Biotest Immune Globulins Revenue Market Share in United States (2013-2018)
Table Kedrion Basic Information List
Table Kedrion Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kedrion Immune Globulins Sales Growth Rate (2013-2018)
Figure Kedrion Immune Globulins Sales Market Share in United States (2013-2018)
Figure Kedrion Immune Globulins Revenue Market Share in United States (2013-2018)
Table Hualan Bio Basic Information List
Table Hualan Bio Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hualan Bio Immune Globulins Sales Growth Rate (2013-2018)
Figure Hualan Bio Immune Globulins Sales Market Share in United States (2013-2018)
Figure Hualan Bio Immune Globulins Revenue Market Share in United States (2013-2018)
Table CNBG Basic Information List
Table CNBG Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CNBG Immune Globulins Sales Growth Rate (2013-2018)
Figure CNBG Immune Globulins Sales Market Share in United States (2013-2018)
Figure CNBG Immune Globulins Revenue Market Share in United States (2013-2018)
Table Shanghai RAAS Basic Information List
Table Shanghai RAAS Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shanghai RAAS Immune Globulins Sales Growth Rate (2013-2018)
Figure Shanghai RAAS Immune Globulins Sales Market Share in United States (2013-2018)
Figure Shanghai RAAS Immune Globulins Revenue Market Share in United States (2013-2018)
Table CBPO Basic Information List
Table CBPO Immune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CBPO Immune Globulins Sales Growth Rate (2013-2018)
Figure CBPO Immune Globulins Sales Market Share in United States (2013-2018)
Figure CBPO Immune Globulins Revenue Market Share in United States (2013-2018)
Table LFB Group Basic Information List
Table BPL Basic Information List
Table Sichuan Yuanda Shuyang Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Globulins
Figure Manufacturing Process Analysis of Immune Globulins
Figure Immune Globulins Industrial Chain Analysis
Table Raw Materials Sources of Immune Globulins Major Players/Suppliers in 2017
Table Major Buyers of Immune Globulins
Table Distributors/Traders List
Figure United States Immune Globulins Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Immune Globulins Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Immune Globulins Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Immune Globulins Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Immune Globulins Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Immune Globulins Sales Volume (K Units) Forecast by Type in 2025
Table United States Immune Globulins Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Immune Globulins Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Immune Globulins Sales Volume (K Units) Forecast by Application in 2025
Table United States Immune Globulins Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Immune Globulins Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immune Globulins Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immune Globulins Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources